Product Information
EZETIMIBE-SIMVASTATIN 10-80 MG is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.4164 per EA under NDC 69238115803. Its NADAC has been published 413 times since Dec 27, 2017.
FDA first approved this application on Nov 21, 2017.
Strength
10; 80 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238115803
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA208831FDA Approved
11/21/2017
On Market Since
11/21/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has been published 413 times since Dec 27, 2017, and over the history we have for it it has declined 86.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4164 per EA |
|---|---|
| All-time high | $3.0554 (Jan 10, 2018) |
| All-time low | $0.3124 (Apr 17, 2024) |
| 52-week high | $0.4457 |
| 52-week low | $0.4164 |
| Median price | $0.9905 |
| Average price | $1.2071 |
| Largest weekly change | -61.3% (Mar 23, 2022) |
| Weeks tracked | 413 |
| Tracking since | Dec 27, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-0.9%
3Y
-30.9%
5Y
-58.0%
All
-86.4%
Last surveyed Nov 19, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-80 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-80 MG, manufactured by Amneal Pharmaceuticals NY LLC, is $0.4164 per EA (NDC 69238115803), effective Nov 19, 2025.
How has the price of EZETIMIBE-SIMVASTATIN 10-80 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has declined 86.4%. It has been tracked across 413 weekly CMS publications since Dec 27, 2017.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-80 MG?
Since Dec 27, 2017, the NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has ranged from a low of $0.3124 (Apr 17, 2024) to a high of $3.0554 (Jan 10, 2018), with a median of $0.9905 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-80 MG?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-80 MG, is $0.3277 per EA — about 21% below EZETIMIBE-SIMVASTATIN 10-80 MG.
Who manufactures EZETIMIBE-SIMVASTATIN 10-80 MG?
EZETIMIBE-SIMVASTATIN 10-80 MG (NDC 69238115803) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.